Wednesday, May 8, 2024

Fw: Ref.: (LML) Infolep monthly overview of new publications on leprosy. May, 2024

 

 


Leprosy Mailing List –  May 8,  2024

 

Ref.:  (LML) Infolep monthly overview of new publications on leprosy. May, 2024

From:  Roos Geutjes & Josephine Breman-Srivastava, Amsterdam, the Netherlands


 


 


Dear colleagues, 

The ESCMID Postgraduate Course - Leprosy: back to the future is taking place later this month. For those attending or presenting; we wish you a fruitful time. Additionally, LRI is hosting the second edition of its "Highlights of LRI Spring Meeting" webinar on the 30th of May. You can register here.

Have you stumbled across the article "Ancient Mycobacterium leprae genome reveals medieval English red squirrels as animal leprosy host"? This study represents the first One Health approach for M. leprae in archaeology. If you have not seen it yet, you can find it in the highlighted publications section below.

This Newsletter additionally has a few non-English articles. If you have any articles that are not written in the English language and are missing from our database,
please share them with us. 

Warm regards,

Roos Geutjes & Josephine Breman-Srivastava

www.infolep.org
info@infolep.org





Practical Materials



Health literacy policies - how can they be developed and implemented? A guide for policy and decision makers
M-POHL . Center of M-POHL at the Austrian National Public Health Institute. 2023.





Highlighted Publications



Ancient Mycobacterium leprae genome reveals medieval English red squirrels as animal leprosy host
Urban C, Blom AA, Avanzi C, et al. Current Biology. Elsevier BV. 2024.
 


Global report on neglected tropical diseases 2024
World Health Organization . World Health Organization . 2024.
 


Evaluating the World Health Organization's SkinNTDs App as a Training Tool for Skin Neglected Tropical Diseases in Ghana and Kenya: Cross-Sectional Study
Cano M, Ruiz-Postigo JA, Macharia P, et al. Journal of Medical Internet Research. JMIR Publications Inc.. 2024.
 


The effects of selected neglected tropical diseases on economic performance at the macrolevel in Africa.
Immurana M, Kisseih K, Abdullahi I, et al. BMC infectious diseases. 2024; 24 (1) : 1-11.





New publications


Feel free to contact us to receive full-text versions if these cannot be found through the Infolep portal.



Experience of people living with leprosy at leprosy settlements in Nigeria
Oke GI, Nsofor I, Abubakar B, et al. Public Health Challenges. Wiley. 2024; 3 (2) : 1-14.
 


Analysis of tuberculosis and leprosy in the pedagogical projects of Medicine courses and the spatial relationship between cases
Vitiritti B, Baruffi P. P, Xavier P. B. Revista Brasileira de Educação Médica. 2024; 48 (2) : 1-8.
 


Using Passive Surveillance to Maintain Elimination as a Public Health Problem for Neglected Tropical Diseases: A Model-Based Exploration.
Minter A, Medley G, Hollingsworth DT. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024; 78 (Supplement_2) : S169-S174.
 


Human Adipose-derived Mesenchymal Stem Cells Colonize and Promote Healing of Leprosy Ulcer by Inducing Neuro-vascularization.
Cheng C, Zhang Y, Jiang H, et al. Stem cells and development. 2024.
 


Unmasking the Hidden Burden: A Delayed Diagnosis of Leprosy Patients With Grade 2 Disability and Its Effects on the Healthcare System in Bangladesh.
Sinha S, Haq M, Ahmad R, et al. Cureus. 2024.
 


Coinfection with Leprosy and Tuberculosis: A Case Series in Malagasy Patients.
Rakotoarisaona M, Razafimaharo T, Sendrasoa F, et al. Infection and drug resistance. 2024.
 


Leprosy
di Chiacchio N, Di Chiacchio N. G, de Nakamura R. C, et al. Atlas of Nail Signs and Disorders with Clinical and Onychoscopic Correlation. Taylor & Francis Group. 2024.
 


Characteristics of Leprae Lesions Based on the Ridley Jopling Classification: Literature Review
Asmin A, Amiruddin M. D, Miranti A. Jurnal Eduhealth. 2024; 15 (2) : 829-844.
 


Assessing Nerve Conduction Velocity as a Diagnostic and Prognostic Indicator in Leprosy Patients: A Cross-Sectional Study
Nisargandha MA, Parwe SD, Lade NR, et al. Cureus. Springer Science and Business Media LLC. 2024.
 


Rheumatological Manifestations of Leprosy- An Observational Study in a Tertiary Care Centre in North-Western India
Ketki , Singh A, Maheshwari R, et al. Indian Journal of Leprosy. Hind Kusht Nivaran Sangh. 2024.
 


Scoping Review: Effectiveness of NDO-LID as new biomarker for leprosy diagnosis
Julianto R, Putri R. D.. Intisari Sains Medis. 2024; 15 (1) : 331-335.
 


Leprosy in Brazil: From the social developments to the diagnosis-therapeutic evolution of the disease
Costa AKM, Silva DCSE, Rosa PHDR, et al. Eyes on Health Sciences V.02. Seven Editora. 2024.
 


A Glimpse of Present Day Perspectives of Stigma Associated with Leprosy : A Qualitative Study from a Tertiary Care Centre in Tezpur area of Assam, India
Sharma L. , Agarwal R, Dadhich K, et al. Indian Journal of Leprosy. Hind Kusht Nivaran Sangh. 2024.
 


Zero Leprosy Strategic Plans: Global and National Level: A Short Communication
Geetha K. Clinical Dermatology Review. Medknow. 2024; 8 (2) : 167-170.
 


Role of Ultrasound-Guided Trucut Nerve Biopsy in the Diagnosis of Pure Neuritic Leprosy: The Way Forward
Suvirya S, Parihar A, Malhotra K, et al. The Arab Journal of Interventional Radiology. 2024.
 


Uncommon Presentations of Leprosy
Yadav A. K, Gupta A. K, Rajkumar . Indian Journal of Leprosy. Hind Kusht Nivaran Sangh. 2024.
 


Bartonella henselae DNA detection in patients with type 1 leprosy reactions for more than six months.
Santos L, Souza L, Goulart I, et al. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2024.
 


Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR).
Penna G, Pontes M, Talhari S, et al. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2024.
 


Análise biomecânica e do design de um dispositivo assistivo para pacientes com hanseníase com grau ii de incapacidade física
Rodrigues MGM, Souza ABDS, Carvalho AADL, et al. Revista Foco. South Florida Publishing LLC. 2024; 17 (3) : 1-11.
 


Integração da atenção primária à saúde no manejo multidisciplinar da hanseníase: um caminho para o cuidado holístico
Cabral AAS, Timbó CM, Timbó EWM, et al. Revista Centro de Pesquisas Avançadas em Qualidade de Vida. Revista CPAQV. 2024; 16 (1) : 1-10.
 


Análise das internações por Hanseníase: Tendências, desafios e abordagens de tratamento
Neta TTF, Oliveira MAMD, Vacari L, et al. Brazilian Journal of Implantology and Health Sciences. Brazilian Journal of Implantology and Health Sciences. 2024; 6 (4) : 1891-1901.
 


Perfil de conhecimento sobre hanseníase entre pacientes de um hospital universitário
Morais RXBD, Santos ALBND, Medeiros ACR, et al. Hansenologia Internationalis: hanseníase e outras doenças infecciosas. Instituto Lauro de Souza Lima. 2024.
 


Incidência de novos casos de hanseníase na região Sudeste (2018-2023): Um estudo ecológico
Salaroli R, Ambrósio MFS, Lordão DBMADV, et al. Brazilian Journal of Implantology and Health Sciences. Brazilian Journal of Implantology and Health Sciences. 2024; 6 (4) : 1752-1765.
 


Hanseníase: fatores de risco e classificações clínicas
Souza TRD, Ribeiro FM, Savio RW, et al. Revista Ibero-Americana de Humanidades, Ciências e Educação. Revista Ibero-Americana de Humanidades, Ciencias e Educacao. 2024; 10 (3) : 2744-2750.
 


Leprosy identified in Sumba Island, eastern Indonesia: elimination targets under threat
Siregar GO, Harianja M, Adella J, et al. The Lancet Regional Health - Southeast Asia. Elsevier BV. 2024.
 


Backward logistic regression analysis of the determinants of the hand function among patients with leprosy: A cross-sectional study.
Wardhani R, Harini M, Anestherita F, et al. Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia. 2024.
 


Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum.
Bandjar F, Tabri F, Muchtar S, et al. Dermatology reports. 2024.
 


A comparative study on the detection of Mycobacterium leprae DNA in urine samples of leprosy patients using Rlep-PCR with other conventional samples.
David D, Das M, Chandra H. Molecular biology reports. 2024.
 


The role of CXCL10 as a biomarker for immunological response among patients with leprosy: a systematic literature review.
Prakoeswa F, Haningtyas N, Dewi L, et al. PeerJ. 2024.
 


Serodiagnosis of paucibacillary and multibacillary leprosy using a recombinant chimeric protein composed of specific B-cell epitopes derived from Mycobacterium leprae proteins.
Assis B, Chaves A, Lage D, et al. Tuberculosis (Edinburgh, Scotland). 2024.
 


Leprosy in Robben Island: Historical and medical insights and a comparative study with India
Srivastava P, Dev PP, Srivastava P, et al. Indian Journal of Dermatology, Venereology and Leprology. Scientific Scholar. 2024.
 


From Theory to Practice: Reflections of a Medical Student's Rural Posting in a Leprosy Hospital
Akpegah G. K. International Journal of Medical Students . 2024; 12 (1) : 106-108.
 


A Cross-sectional Study to Assess the Mental Health Status of Leprosy - Affected Persons in Hyderabad, Telangana, India
Anusha V, Mohiuddin S. A, Ananda K. G, et al. Indian Journal of Leprosy. Hind Kusht Nivaran Sangh. 2024.
 


Hansen's Disease: A Practical Update on a Neglected Globally Significant Infection
Benlamkadam S, Errahmany A, Raymond K, et al. Cureus. Springer Science and Business Media LLC. 2024.
 


Clinico-epidemiological Profile of 2000 Leprosy Cases Treated at a Tertiary Care Centre of Rajasthan, India from 2011 to 2020
Khan I, Gupta N, Paliwal V, et al. Indian Journal of Leprosy. Hind Kusht Nivaran Sangh. 2024.
 


Epidemiological Study of Co-infection of Leprosy and COVID-19 in the State of Mato Grosso, 2020
Alencar R. D. S. C. S. D, Damazo A. S. Indian Journal of Leprosy. Hind Kusht Nivaran Sangh. 2024.
 


Health-Related Quality of Life Study of Leprosy Affected People of a Leprosarium of Northern India
Bhat L, Khan N, Vaida N, et al. Indian Journal of Leprosy. Hind Kusht Nivaran Sangh. 2024.
 


Whole blood transcriptomics reveals the enrichment of neutrophil activation pathways during erythema nodosum leprosum reaction
Rosa TLSA, Leal-Calvo T, Tavares IF, et al. Frontiers in Immunology. Frontiers Media SA. 2024.
 


Clinicohistopathological Evaluation of skin biopsies in Hansen's Disease - A prospective study at a tertiary care centre
Tambse M. P, Nikumbh D. B, Thakare S. S, et al. Journal of Cardiovascular Disease Research . 2024; 15 (2) : 1681-1690.
 


A randomised Trial of Autologous Blood products, leukocyte and platelet-rich fibrin (L-PRF), to promote ulcer healing in LEprosy: The TABLE trial.
Napit I, Shrestha D, Choudhury S, et al. PLoS neglected tropical diseases. 2024; 18 (5) : 1-19.
 


A recombinant chimeric antigen constructed with B-cell epitopes from Mycobacterium leprae hypothetical proteins is effective for the diagnosis of leprosy
Assis BP, Chaves AT, Lage DP, et al. Diagnostic Microbiology and Infectious Disease. Elsevier BV. 2024.
 


[Chronic communicable and non-communicable pathology and skin pathology of the migrant patient].
Lugo S, Gol C, Martínez ÁM, et al. Atencion primaria. 2024; 56 (7) : 102922.
 


Creation and development of support groups for leprosy self-care in a state in the northeast of Brazil
do Nascimento R. D, de Sousa I. M. C, de Melo C. P. L, et al. Physis: Revista de Saúde Coletiva. 2024.
 


Desafios socioeconômicos e culturais vivenciados por um jovem com Hanseníase: Relato de caso
Lima CS, Brito MC, Silva KMMD, et al. Research, Society and Development. Research, Society and Development. 2024; 13 (4) : 1-9.
 


Atualizações e abordagens clínicas da hanseniase no âmbito dermatológico atual
Locateli AGO, Borin CF, Silva ICBE, et al. Brazilian Journal of Health Review. South Florida Publishing LLC. 2024; 7 (2) : 1-22.
 


Datos epidemiológicos de la casuística de lepra en un hospital de tercer nivel de 1990 a 2023
Ruiz K. U. R, Vincent N. A. M, Arenas R, et al. Dermatología Revista Mexicana. 2024; 68 (2) : 170-180.
 


Lepra: una enfermedad de la piel olvidada
Solana A. D. C, Navarrete M. R. Dermatología Revista Mexicana. 2024; 68 (2) : 151-152.
 


Hanseníase: olhar epidemiológico nas regiões brasileiras nos últimos anos
Sousa LS, Vieira SMM, Rabelo ECS, et al. Brazilian Journal of Implantology and Health Sciences. Brazilian Journal of Implantology and Health Sciences. 2024; 6 (4) : 647-656.







Case Reports



Infiltrated and nodular pinna in lepromatous leprosy.
Vangala N, Madke B, Kashikar Y, et al. BMJ case reports. 2024.
 


Lepromatous Leprosy Masquerading as Infective and Inflammatory Skin Conditions: A Series of Four Cases
Ramasamy S. V, Vellaisamy S. G, Manickam N, et al. Journal of Communicable Diseases. 2024; 56 (1) : 145-151.
 


A case of leprosy in an immunocompromised traveller.
Pelser S, Geluk A, Vissers W, et al. Journal of travel medicine. 2024.
 


Pseudokebnorization of leprosy: A unique phenomenon from mpox virus coinfection.
Obi A, Varma A, Zhou L, et al. JAAD case reports. 2024.
 


Pressure Stockings for Edematous Feet in the Lepra Reaction: An Inexpensive Patronage
Ahmed G. Cureus. Springer Science and Business Media LLC. 2024.
 


A case of lepromatous leprosy in a background of chronic hepatitis B infection
Jayashankar CA, Prakash B, Prashanthi SVSR, et al. Journal of Family Medicine and Primary Care. Medknow. 2024; 13 (4) : 1559-1562.
 


A challenging case of borderline lepromatous leprosy non-responsive to WHO-MDT: exploring approaches beyond WHO-MDT.
Sharma A, Parkhi M, Chhabra S, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2024.
 


Onychomycosis Caused by Aspergillus in a Patient with Leprosy: A Case Report
Hertanto A, Yulianto Listiawan M, Ervianti E, et al. Journal of Mycology and Infection. Korean Society for Medical Mycology. 2024.
 


Case report of a 28 years old woman with lepromatous leprosy mimicking systemic lupus erythematosus
Wijaya E, Komarasari E, Esti PK. Bali Dermatology Venereology and Aesthetic Journal. Sanglah Hospital - Udayana University. 2024.
 


Joint-related manifestations of leprosy: A case report
Bashiri H, Ardakani M. E, Zahedi M, et al. Rheumatology Research. 2024.
 


Erythema Nodosum Leprosum Reaction Masquerading as Rheumatoid Arthritis
Deo K, Reddy A, Manoj R, et al. Cureus. Springer Science and Business Media LLC. 2024; 16 (3) : 1-4.
 


Lepra lepromatosa en un receptor de trasplante cardiaco: un reto clínico y terapéutico
López R. F. R, Hurtado D. I. C, Molinares L. I. L. Dermatología Revista Mexicana. 2024; 68 (2) : 279-281.
 


Lepra Virchowiana o Lepromatosa en Paciente Masculino. Reporte de Caso
Ramírez Honores JF, Choez Abendaño YI, Paz Ceron YM, et al. Ciencia Latina Revista Científica Multidisciplinar. Asociacion Latinoamericana para el Avance de la Ciencia. 2024; 8 (1) : 9119-9126.





News & Events



Highlights of LRI Spring Meeting - Webinar
May 30, 2024; 14:00-16:30 CEST; Online.

"Highlights of LRI Spring Meeting 2024" is an online event will showcase selected project progress presentations from the in-person LRI Spring meeting and a special session on LRI research impact.
The event is open to everyone with an interest in leprosy research, and participation is completely free-of-charge. You can register for the webinar by
clicking here.
 


COR-NTD Meeting for the Pacific Islands
September 25-26, 2024; Brisbane, Australia. 

The 2nd annual Regional COR-NTD Meeting for the Pacific Islands will take place from September 25 to 26, 2024 in Brisbane, Australia. The goal of this meeting is to bring together key stakeholders to address how to eliminate lymphatic filariasis, scabies, trachoma, leprosy and other NTDs from the region.
 


ESCMID Postgraduate Course - Leprosy: back to the future.

May 20-22, 2024, Bergen, Norway.

ESCMID and ILEP have co-organized Leprosy: back to the future, a 3-day postgraduate training program in Bergen, Norway. The program focuses on medical aspects of leprosy so it is designed mostly for medical practitioners who would benefit from learning or updating on current issues in leprosy, especially new approaches to prevention and discussions about 'Zero Leprosy'. However it may also be of interest to program administrators or managers who are already familiar with leprosy. 


NNN Conference 2024
October 1-3, 2024; Kuala Lumpur, Malaysia.

The NNN Annual Conference 2024 will take place from 1st of October - 3rd of October, 2024, in Kuala Lumpur Malaysia. The theme for the conference is: "Collaboration for Change: Fostering Global Equity and Strengthening Community Engagement in NTDs."
Early Bird Registration is open until the 31st of May, 2024.
 


Injaz Fellowship for Disease Elimination

GLIDE announced the Injaz Fellowship for Disease Elimination for the 2024-2025 cycle, an innovative program designed to advance global efforts to eliminate and eradicate infectious diseases. The focus diseases for this fellowship are Neglected Tropical Diseases including Lymphatic Filariasis, Onchocerciasis, Polio, and Malaria. The aim is to equip selected fellows with the necessary knowledge, skills, and leadership strategies to lead innovative strategies in disease elimination. Application deadline is the 10th of May, 2024. 
 


Conference on Neglected Tropical Diseases 2024
November 14-16, 2024, Nairobi; Kenya.

The 1st edition of the Conference on Neglected Tropical Diseases, organized by AME is tentatively scheduled from 14-16 Novermber in Nairobi, Kenya, as a hybrid meeting. The abstract-driven conference proposes a platform to disseminate new advancements, real-world data, implementation challenges, and novel governing models to discuss and generate solutions for cross-cutting topics and ultimately reduce the disease burden and societal impact of NTDs. This proposal supports the progress in foundational pillars of the WHO Roadmap by facilitating evidence-based program implementation, leveraging the cross-cutting approach, and providing a forum to discuss a paradigm shift toward country ownership of elimination programs.





Links



Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
 


ALLF - Official website of the Association des Léprologues de Langue Française
 


LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
 


InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)


ILEP newsletter archive


GPZL newsletter subscription


WHO Goodwill Ambassador's Leprosy Bulletin


Leprosy Review


Leprosy Review Repository (1928-2001)


Fontilles Revista de Leprología


Indian Journal of Leprosy


Hansenologia Internationalis


HARP - database of Hansen's Disease Antimicrobial Resistance Profiles




GDPR & the Infolep newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our
privacy statement and mailing list.

Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.

Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can
update your preferences or unsubscribe from this list at any time.






Copyright © 2024 Infolep, All rights reserved.
You are receiving this mail because you opted in at our website.


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/85c7d065-1f3e-4732-96dc-c1105200f792n%40googlegroups.com.

Friday, May 3, 2024

Fw: Ref.: (LML) Reflections on LRI Spring Meeting – Register for online Highlights event on May 30th

 

Leprosy Mailing List –  May 3,  2024

 

Ref.:  (LML) Reflections on LRI Spring Meeting – Register for online Highlights event on May 30th

From:  LRI, Amsterdam, the Netherlands



 







In this communication, we are pleased to share reflections of the in-person LRI Spring Meeting, and call for registration for the online 'Highlights of LRI Spring Meeting' event.




Reflections on in-person LRI Spring Meeting

The ninth annual Leprosy Research Initiative Spring Meeting was held on 17-19 April 2024 in Eindhoven, the Netherlands. This in-person event brought together nearly 100 attendees from 25 countries, including LRI-funded researchers, LRI committee members, partners of LRI, representatives of collaborating organisations, and other attendees with a particular interest in leprosy research.






The Spring Meeting is an important event for presenting and discussing progress and results from ongoing LRI-funded research projects and a platform for shared learning and networking. Dr. Suzan Trienekens, Coordinator of LRI shares: "It is an absolute honour to organise this event for the LRI community. Although we are diverse across disciplines and countries, expertise and experience, we share the strong commitment to elimination of leprosy and NTDs through impactful research. You can really feel the buzz of sharing of insights, the forming of new connections and the strengthening of collaborations at the LRI Spring Meeting."
 

The two and half days were filled with scientific presentations, interactive break-out sessions, and networking opportunities. In total, 39 progress presentations were given on ongoing projects covering all five LRI research priorities, including from the two new research capacity strengthening grant awardees. Additionally, Dr Subbanna Jonnalagada (WHO Global Leprosy Programme) and Dr Wim van Brakel (NLR) gave the keynote presentation on the global leprosy situation and progress towards interruption of transmission and elimination. Plenary presentations were also given by several LRI collaborating organisations on their invaluable work towards our shared aim of beating leprosy and NTDs. On Friday morning, participants attended break-out sessions on topics of their preference including research impact, endpoints for clinical trials, and stakeholders speed dating, all sparking lively discussions and new connections.


The LRI Spring Meeting marked another special moment. LRI's Director, Linda Hummel and Iñigo Lasa, Anesvad Foundation's General Director, signed the agreement for the RESILIENTD grant, solidifying the commitment to four calls for proposals. The RESILIENTD grant, funded by Anesvad Foundation and managed by LRI, is developed to better understand social determinants of health within the context of skin NTDs, including leprosy, with a focus on sub-Saharan Africa. We hope funding RESILIENTD research projects will accelerate and strengthen efforts to combat these often-overlooked diseases and the persons affected.


We are looking forward to the outcomes of the first RESILIENTD call coming December and are working hard behind the scenes to support meaningful contributions to the control of skin-NTDs in the years ahead.






We look back on an inspiring LRI Spring Meeting 2024, also reflected in the overwhelmingly positive feedback from the participants: "Every year the different aspects of leprosy covered during the LRI Spring Meeting give a very good impression of why leprosy research is still necessary and relevant."
"A powerful forum with a very talented and committed group of people."

 
We will review participants' suggestions and look forward to welcome you at the next LRI Spring Meeting!






Online 'Highlights of LRI Spring Meeting' event coming on May 30th


Last year, LRI hosted the online "Highlights of LRI Spring Meeting" event for the first time, and after its success in reaching global audiences, the webinar is returning!

On May 30th, from 14:00 to 16:30 CEST, the "Highlights of LRI Spring Meeting 2024" will take place to allow for global participation and share important findings from LRI funded projects. The event will include the showcasing of selected project progress presentations from the in-person meeting and a special session on LRI research impact.

The event is open to everyone with an interest in leprosy research, and participation is completely free-of-charge. During the webinar, the possibility to ask the presenters questions will be given, so don't miss out!

To register your interest in the event, please complete the registration form (accessible via the button below), and you will receive the meeting link. Further event details and the program will soon be available on the LRI website and LinkedIn channel, as well as through newsletter updates.

We are excited to welcome you online soon!

 





















LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/335c7488-a6ed-4c38-a2f8-bbf4996adcc8n%40googlegroups.com.